Largest fake drug haul in Europe from India

12 October 2008

Customs officers at Brussels' Zaventem Airport, Belgium, have seized three shipments of counterfeit drugs in transit from Mumbai, India to Togo. According to local media reports, at over 2.1 million tablets, the haul is the biggest ever uncovered in the European Union.

The two products targeted by the counterfeiters were: Fansidar (pyrimethamine sulfadoxine), an antimalarial made under license from Swiss drug major Roche; and Tramal (tramadol HCl), a painkiller originally manufactured by German pharmaceutical firm Grunenthal.

A spokesman for the Belgian Customs and Excise, Lieven Muylaert, told Le Soir that most of the seized agents were imitations of Fansidar. It is considered likely that after shipment to Casablanca, Morocco, then onwards to Togo, the drugs would have been circulated in several countries in the region, for example, neighboring Benin, Burkina Faso and Ghana. Mr Muylaert told reporters that customs officers had been suspicious of the packages, which were found to have spelling mistakes on the labeling.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight